Immunomodulators
These sections summarize the data on IL-6 inhibitors, kinase inhibitors, and other immunomodulators.
Review the Panel’s recommendations on the use of immunomodulators in patients with COVID-19.
Corticosteroids are anti-inflammatory drugs that may benefit particular patients with COVID-19.
IL-6 inhibitors are a group of anti-inflammatory drugs that are being evaluated to treat COVID-19.
JAK and BTK inhibitors are immunomodulatory drugs that are being evaluated to treat COVID-19.
Review the data on the use of GM-CSF inhibitors for the treatment of COVID-19.
IL-1 inhibitors are a group of anti-inflammatory drugs that are being evaluated to treat COVID-19.
This table summarizes key characteristics of immunomodulators that have been evaluated for COVID-19.